MOSAIC® 310C31 (UDI 00885074247878)Recalls & reported problems
Medtronic, Inc. · VALVE 310C31 MOSAIC MIT CINCH US · Class 3 · Implant
Data updated Oct 13, 2026 from official FDA records · Editorial policy
Quick summary
This Medtronic Mosaic 310C31 is a 31mm bioprosthetic valve used to replace a damaged mitral valve. Most reports describe the valve leaflets becoming stiff or thickened with calcium deposits, narrowing the valve opening or letting blood leak backward, sometimes with shortness of breath and fatigue, and several patients needing the valve replaced years after implantation. There are 49 reports, including 1 death and 47 injuries.
AI-generated from the FDA records on this page and checked automatically against the numbers below. Read the details before relying on it.
- Adverse event reports
- 49
- Deaths reported
- 1
- Injuries reported
- 47
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 49 adverse event reports that list this exact device (DI 00885074247878), received between Nov 20, 2017 and Apr 17, 2025 — classified as 1 death, 47 injuries, 1 malfunction.
The most frequently reported specific device problem is “Insufficient Device Problem Information” (41 reports).
3 other recalls cover devices cleared under the same FDA submission (P990064); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.
Reports received per month
Most reported problems
Device problems
- Insufficient Device Problem Information41
- Calcified6
- Device Stenosis3
- Intravalvular regurgitation3
- Adverse Event Without Identified Device or Use Problem2
- Degraded2
- Incomplete Coaptation2
- Material Split, Cut or Torn2
Patient problems
- Insufficient Information21
- No Information13
- Mitral Valve Insufficiency/ Regurgitation11
- Mitral Valve Stenosis10
- Mitral Regurgitation6
- Calcium Deposits/Calcification4
- Cusp Tear4
- Dyspnea3
Recent adverse event reports
The 25 most recent of 49 reports, in the reporter's own words as published by the FDA.
InjuryApr 17, 2025Device Stenosis; Intravalvular regurgitation; Device Stenosis; Intravalvular regurgitation
MEDTRONIC RECEIVED INFORMATION THAT 15 YEARS AND 11 MONTHS POST IMPLANT OF THIS 31MM MITRAL BIOPROSTHETIC VALVE, IT WAS EXPLANTED AND REPLACED WITH A 33MM VALVE OF A DIFFERENT MODEL. THE REASON FOR THE REPLACEMENT WAS REPORTED AS SEVERE MITRAL STENOSIS AND SEVERE MITRAL REGURGITATION. IT WAS ALSO REPORTED THAT THE PATIENT HAD SYMPTOMS OF SHORTNESS OF BREATH AND FATIGUE. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: Dyspnea; Fatigue; Mitral Valve Insufficiency/ Regurgitation; Mitral Valve Stenosis
MAUDE report 21862324 ↗DeathMar 11, 2025Insufficient Device Problem Information; Insufficient Device Problem Information
MEDTRONIC RECEIVED INFORMATION THAT 13 YEARS AND 10 MONTHS POST IMPLANT OF THIS 31MM MITRAL BIOPROSTHETIC VALVE, THE PATIENT DIED. THE CAUSE OF DEATH WAS NOT RECEIVED. THEREFORE, RELATEDNESS OF THE DEATH TO THE VALVE COULD NOT BE EXCLUDED. IT IS UNKNOWN WHETHER AN AUTOPSY WAS PERFORMED.
Patient problems: Insufficient Information
MAUDE report 21570483 ↗InjuryFeb 26, 2025Calcified; Incomplete Coaptation; Material Split, Cut or Torn; Device Stenosis; Intravalvular regurgitation; Calcified; Incomplete Coaptation; Material Split, Cut or Torn; Device Stenosis; Intravalvular regurgitation
IT WAS REPORTED THAT THAT 15 YEARS AND 7 MONTHS POST IMPLANT OF THIS 31MM MITRAL BIOPROSTHETIC VALVE, IT WAS EXPLANTED AND REPLACED WITH A 31MM MITRAL BIOPROSTHETIC VALVE OF THE SAME MODEL. THE REASON FOR THE REPLACEMENT WAS REPORTED AS SEVERE MITRAL STENOSIS AND MILD MITRAL REGURGITATION. IT WAS FURTHER REPORTED THAT THERE IS RESTRICTED MOVEMENT OF 2 OF THE 3 LEAFLETS. IT WAS NOTED THAT THE PATIENT WAS SYMPTOMATIC INCLUDING EXPERIENCING SHORTNESS OF BREATH (SOB) ON EXERTION AND CHEST HEAVINESS. A CORONARY ARTERY BYPASS GRAFT (CABG) PROCEDURE WAS ALSO PERFORMED DURING THE SAME PROCEDURE DUE TO THE PATIENTS RIGHT CORONARY ARTERY AND VEIN GRAFT BEING OCCLUDED. THE TRICUSPID VALVE WAS ALSO REPAIRED DURING THE PROCEDURE. IT WAS MENTIONED THAT IT WAS OBSERVED THAT THE EXPLANTED VALVE WAS HEAVILY CALCIFIED AND HAD A TORN LEAFLET RESULTING IN PROLAPSE. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: Chest Pain; Dyspnea; Mitral Valve Insufficiency/ Regurgitation; Mitral Valve Stenosis
MAUDE report 21471392 ↗MalfunctionJan 14, 2025Device Stenosis; Device Stenosis
MEDTRONIC RECEIVED INFORMATION FROM A COMPETITOR REPRESENTATIVE THAT 12 YEARS AND 2 MONTHS POST IMPLANT OF THIS 31MM MITRAL BIOPROSTHETIC VALVE, IT WAS REPORTED THAT A "POSSIBLE REPLACEMENT" MAY OCCUR. THE REASON FOR THE REPLACEMENT WAS NOT REPORTED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED. ADDITIONALLY, INFORMATION WAS REPORTED THAT THE PATIENT IS BEING EVALUATED FOR A TRANSCATHETER VALVE-IN-VALVE REPLACEMENT. THE REASON FOR EVALUATION WAS REPORTED AS THE PATIENTS MITRAL VALVE BECOMING STENOTIC. NO INTERVENTION OR ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: Mitral Valve Stenosis
MAUDE report 21149100 ↗InjuryOct 16, 2024Insufficient Device Problem Information; Insufficient Device Problem Information
MEDTRONIC RECEIVED INFORMATION THAT 1 YEAR AND 6 MONTHS POST IMPLANT OF THIS 31MM MITRAL BIOPROSTHETIC VALVE, IT WAS EXPLANTED AND REPLACED WITH A 31MM VALVE OF THE SAME MODEL. THE REASON FOR THE REPLACEMENT WAS NOT REPORTED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: Insufficient Information
MAUDE report 20464624 ↗InjuryOct 4, 2024Insufficient Device Problem Information; Insufficient Device Problem Information
MEDTRONIC RECEIVED INFORMATION THAT 16 YEARS AND 2 MONTHS POST IMPLANT OF THIS 31MM MITRAL BIOPROSTHETIC VALVE IMPLANTED IN THE TRICUSPID POSITION, IT WAS REPORTED THAT THE PATIENT IS A CANDIDATE FOR A BALLOON VALVULOPLASTY. A VALVULOPLASTY MAY BE NEEDED TO ALLOW A LARGER ORIFICE FOR THE AORTIC VALVE TO ALLOW A TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR). NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: Insufficient Information
MAUDE report 20369774 ↗InjuryApr 29, 2024Insufficient Device Problem Information; Insufficient Device Problem Information
MEDTRONIC RECEIVED INFORMATION THAT 9 YEARS AND 5 MONTHS POST IMPLANT OF THIS 31MM MITRAL BIOPROSTHETIC VALVE, IT WAS EXPLANTED AND REPLACED WITH A 29MM VALVE OF THE SAME MODEL. THE REASON FOR THE REPLACEMENT WAS NOT REPORTED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: Insufficient Information
MAUDE report 19201841 ↗InjuryApr 2, 2024Insufficient Device Problem Information; Patient Device Interaction Problem; Insufficient Device Problem Information; Patient Device Interaction Problem
MEDTRONIC RECEIVED INFORMATION THAT 7 YEARS AND 2 MONTHS POST IMPLANT OF THIS 31MM MITRAL BIOPROSTHETIC VALVE, IT WAS EXPLANTED AND REPLACED WITH A 29MM BIOPROSTHETIC VALVE. THE REASON FOR THE REPLACEMENT WAS NOT REPORTED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: Endocarditis; Insufficient Information
MAUDE report 19027104 ↗InjuryNov 30, 2023Patient Device Interaction Problem; Patient Device Interaction Problem
MEDTRONIC RECEIVED INFORMATION THAT 3 DAYS POST IMPLANT OF THIS 31 MITRAL BIOPROSTHETIC VALVE, A PERMANENT PACEMAKER WAS IMPLANTED. THE REASON FOR THE PERMANENT PACEMAKER WAS NOT REPORTED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: Insufficient Information; Non specific EKG/ECG Changes
MAUDE report 18238834 ↗InjuryNov 6, 2023Insufficient Device Problem Information; Insufficient Device Problem Information
MEDTRONIC RECEIVED INFORMATION THAT 8 YEARS AND 6 MONTHS POST IMPLANT OF THIS 31MM MITRAL BIOPROSTHETIC VALVE, IT WAS EXPLANTED AND REPLACED WITH A 31MM VALVE OF THE SAME MAKE AND MODEL. THE REASON FOR THE REPLACEMENT WAS NOT REPORTED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: Insufficient Information
MAUDE report 18075461 ↗InjuryOct 10, 2023Insufficient Device Problem Information; Insufficient Device Problem Information
MEDTRONIC RECEIVED INFORMATION THAT 12 YEARS AND 1 MONTH POST IMPLANT OF THIS 31MM MITRAL BIOPROSTHETIC VALVE, IT WAS EXPLANTED AND REPLACED WITH A 29MM VALVE OF THE SAME MODEL. THE REASON FOR THE REPLACEMENT WAS NOT REPORTED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: Insufficient Information
MAUDE report 17903592 ↗InjuryOct 2, 2023Insufficient Device Problem Information; Intravalvular regurgitation; Insufficient Device Problem Information; Intravalvular regurgitation
MEDTRONIC RECEIVED INFORMATION THAT 14 YEARS AND 2 MONTHS POST IMPLANT OF THIS 31MM MITRAL BIOPROSTHETIC VALVE, IT WAS EXPLANTED AND REPLACED WITH A 33MM VALVE OF THE SAME MODEL. THE REASON FOR THE REPLACEMENT WAS NOT REPORTED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: Insufficient Information; Mitral Valve Insufficiency/ Regurgitation
MAUDE report 17850048 ↗InjurySep 22, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
MEDTRONIC RECEIVED INFORMATION THAT 1 YEAR AND 4 MONTHS POST IMPLANT OF THIS 31MM MITRAL BIOPROSTHETIC VALVE, IT WAS EXPLANTED AND REPLACED WITH A VALVE OF THE SAME MODEL AND SIZE. THE REASON FOR THE REPLACEMENT WAS REPORTED AS A LARGE AND MOBILE 1-1.5CM VEGETATION ON THE INLET PORTION OF THE POSTERIOR VALVE LEAFLET DUE TO AN INFECTION. IT WAS ALSO REPORTED THAT 7 DAYS PRIOR TO EXPLANT, THE PATIENT EXPERIENCED AN ACUTE INFERIOR MYOCARDIAL INFARCTION (MI) WHICH WAS DUE TO AN EMBOLUS IN THE ORIGIN OF THE POSTERIOR DESCENDING ARTERY CAUSED BY THE INFECTION. IT WAS ALSO REPORTED THAT THE BLOOD CULTURE RESULTS WERE NEGATIVE FOR ENDOCARDITIS. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: Myocardial Infarction; Unspecified Infection
MAUDE report 17798656 ↗InjuryJun 22, 2023Insufficient Device Problem Information; Insufficient Device Problem Information
MEDTRONIC RECEIVED INFORMATION THAT 12 YEARS AND 9 MONTHS POST IMPLANT OF THIS 31MM MITRAL BIOPROSTHETIC VALVE, IT WAS EXPLANTED AND REPLACED WITH A 33MM VALVE OF THE SAME MAKE AND MODEL. THE REASON FOR THE REPLACEMENT WAS NOT REPORTED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: Insufficient Information
MAUDE report 17183472 ↗InjuryJun 5, 2023Insufficient Device Problem Information; Insufficient Device Problem Information
MEDTRONIC RECEIVED INFORMATION THAT 16 YEARS AND 2 MONTHS POST IMPLANT OF THIS 31MM MITRAL BIOPROSTHETIC VALVE, IT WAS EXPLANTED AND REPLACED WITH A 33MM MITRAL BIOPROSTHETIC VALVE OF THE SAME MODEL. THE REASON FOR THE REPLACEMENT WAS NOT REPORTED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: Insufficient Information
MAUDE report 17060656 ↗InjuryApr 25, 2023Insufficient Device Problem Information; Insufficient Device Problem Information
MEDTRONIC RECEIVED INFORMATION THAT 10 YEARS AND 9 MONTHS POST IMPLANT OF THIS 31MM MITRAL BIOPROSTHETIC VALVE, IT WAS EXPLANTED AND REPLACED WITH A 29MM VALVE OF THE SAME MODEL. THE REASON FOR THE REPLACEMENT WAS NOT REPORTED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: Insufficient Information
MAUDE report 16811246 ↗InjuryApr 12, 2023Calcified; Degraded; Insufficient Device Problem Information; Calcified; Degraded; Insufficient Device Problem Information
MEDTRONIC RECEIVED ADDITIONAL INFORMATION WHICH STATED THAT THE REASON FOR REPLACEMENT WAS SEVERE MITRAL REGURGITATION. IT WAS REPORTED THAT THE PATIENT HAD DEVELOPED ENDOCARDITIS AND ANTIBIOTICS WERE ADMINISTERED. IT WAS REPORTED THAT DURING THE EXPLANT PROCEDURE, THE VALVE WAS NOTED TO BE COMPLETELY DEGENERATED. IT WAS ALSO STATED THAT CALCIFICATION WAS PRESENT ON THE VALVE. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: Endocarditis; Insufficient Information; Mitral Valve Insufficiency/ Regurgitation
MAUDE report 16728633 ↗InjuryFeb 3, 2023Insufficient Device Problem Information; Insufficient Device Problem Information
MEDTRONIC RECEIVED INFORMATION FROM THE PATIENT THAT 14 YEARS AND 9 MONTHS POST IMPLANT OF THIS AORTIC BIOPROSTHETIC VALVE, IT WAS EXPLANTED AND REPLACED WITH A 31MM NON-MEDTRONIC VALVE. THE REASON FOR THE REPLACEMENT WAS REPORTED AS SEVERE MITRAL REGURGITATION. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: Mitral Valve Insufficiency/ Regurgitation
MAUDE report 16289997 ↗InjuryDec 12, 2022Insufficient Device Problem Information; Insufficient Device Problem Information
MEDTRONIC RECEIVED INFORMATION THAT 9 YEARS AND 10 MONTHS POST IMPLANT OF THIS 31MM MITRAL BIOPROSTHETIC VALVE, IT WAS EXPLANTED AND REPLACED WITH A 27MM MITRAL BIOPROSTHETIC VALVE OF THE SAME MODEL. THE REASON FOR THE REPLACEMENT WAS NOT REPORTED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: Insufficient Information
MAUDE report 15964803 ↗InjuryNov 30, 2022Insufficient Device Problem Information; Insufficient Device Problem Information
MEDTRONIC RECEIVED INFORMATION THAT 8 YEARS AND 2 MONTHS POST IMPLANT OF THIS 31MM MITRAL BIOPROSTHETIC VALVE, IT WAS EXPLANTED AND REPLACED WITH A 31MM VALVE OF THE SAME EXACT MAKE AND MODEL. THE REASON FOR THE REPLACEMENT WAS REPORTED AS SEVERE MITRAL INSUFFICIENCY DUE TO A RUPTURED AND FLAIL BIOPROSTHETIC VALVE LEAFLET. IT WAS STATED THAT THERE WAS MODERATE CALCIFICATION PRESENT AROUND THE ANNULUS. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: Calcium Deposits/Calcification; Cusp Tear; Mitral Valve Insufficiency/ Regurgitation
MAUDE report 15886719 ↗InjurySep 27, 2022Insufficient Device Problem Information; Insufficient Device Problem Information
MEDTRONIC RECEIVED INFORMATION THAT 10 YEARS AND 11 MONTHS POST IMPLANT OF THIS 31 MM MITRAL BIOPROSTHETIC VALVE, IT WAS EXPLANTED AND REPLACED WITH A 31 MM VALVE OF THE SAME MODEL. THE REASON FOR THE REPLACEMENT WAS NOT REPORTED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: Insufficient Information
MAUDE report 15494133 ↗InjurySep 13, 2022Insufficient Device Problem Information; Insufficient Device Problem Information
MEDTRONIC RECEIVED INFORMATION FROM THE PATIENT THAT 10 YEARS AND 2 MONTHS POST IMPLANT OF THIS 31MM MITRAL BIOPROSTHETIC VALVE, IT WAS EXPLANTED AND REPLACED WITH A NON-MEDTRONIC DEVICE. THE REASON FOR THE REPLACEMENT WAS NOT REPORTED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: Insufficient Information
MAUDE report 15410945 ↗InjuryJul 14, 2022Insufficient Device Problem Information; Material Split, Cut or Torn; Insufficient Device Problem Information; Material Split, Cut or Torn
MEDTRONIC RECEIVED INFORMATION FROM THE PATIENT THAT 14 YEARS AND 7 MONTHS POST IMPLANT OF THIS MITRAL BIOPROSTHETIC VALVE, THE PATIENT WAS RECEIVING ABLATION AND THE PROCEDURE HAD TO BE STOPPED BECAUSE THE MITRAL VALVE WAS TOO DAMAGED AND WAS LEAKING EXCESSIVELY. IT WAS FURTHER SPECIFIED THAT THE PATIENT IS EXPERIENCING SEVERE MITRAL REGURGITATION. NO INTERVENTION OR ADVERSE PATIENT EFFECTS WERE REPORTED. SUBSEQUENTLY, 12 DAYS LATER, THE VALVE WAS EXPLANTED AND REPLACED WITH A NON-MEDTRONIC VALVE. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: Cusp Tear; Mitral Valve Insufficiency/ Regurgitation
MAUDE report 15015039 ↗InjuryJun 16, 2022Calcified; Incomplete Coaptation; Insufficient Device Problem Information; Calcified; Incomplete Coaptation; Insufficient Device Problem Information
MEDTRONIC RECEIVED INFORMATION THAT 15 YEARS AND 7 MONTHS POST IMPLANT OF THIS 31MM MITRAL BIOPROSTHETIC VALVE, IT WAS EXPLANTED AND REPLACED WITH A 31MM MITRAL BIOPROSTHETIC VALVE OF THE SAME MODEL. THE REASON FOR THE REPLACEMENT WAS NOT REPORTED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: Calcium Deposits/Calcification; Insufficient Information; Mitral Valve Insufficiency/ Regurgitation
MAUDE report 14714461 ↗InjurySep 23, 2021Insufficient Device Problem Information; Insufficient Device Problem Information
MEDTRONIC RECEIVED INFORMATION THAT 14 YEARS AND 7 MONTHS POST IMPLANT OF THIS 31MM MITRAL BIOPROSTHETIC VALVE, IT WAS EXPLANTED AND REPLACED WITH A 29MM VALVE OF THE SAME MODEL. THE REASON FOR THE REPLACEMENT WAS REPORTED AS SEVERE MITRAL INSUFFICIENCY. OF NOTE, WHILE ATTEMPTING TO ACCESS THE PREVIOUSLY IMPLANTED MITRAL VALVE, THE PATIENT'S INFERIOR VENA CAVA TORE. THIS WAS SUCCESSFULLY REPAIRED WITH A PATCH WHILE THE PATIENT WAS IN HYPOTHERMIC CIRCULATORY ARREST. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: Mitral Valve Insufficiency/ Regurgitation
MAUDE report 12522259 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under P990064. One submission often covers many models, so check the product and lot details in each record.
- Z-1880-2019 · May 21, 2019 · TerminatedMosaic 310 Bioprosthesis, Mitral, REF 310C29 - Product Usage: Replacement of malfunctioning native or prosthetic aortic and/or mitral valves.
- Z-1881-2019 · May 21, 2019 · TerminatedMosaic 310 Bioprosthesis, Mitral, REF 310C31 - Product Usage: Replacement of malfunctioning native or prosthetic aortic and/or mitral valves.
- Z-1225-2009 · Jan 26, 2009 · TerminatedMedtronic Mosaic Porcine Bioprostheses with Cinch, Heart Valve; Model 305; Catalog #s 305C21AA, 305C2701, 305C2301, 305C2501, and 305C2901; Sterile LC; Rx only; Medtronic Inc 710 M
Other heart-valve, non-allograft tissue devices
- INSPIRIS RESILIA AORTIC VALVE 11500AEdwards Lifesciences LLC · Heart-Valve, Non-Allograft Tissue2 deaths404 reports
- INSPIRIS RESILIA AORTIC VALVE 11500AEdwards Lifesciences LLC · Heart-Valve, Non-Allograft Tissue385 reports
- PERCEVAL PVS23Corcym Canada Corp · heart-valve, non-allograft tissue26 deaths337 reports
- MOSAIC® 305C23Medtronic, Inc. · heart-valve, non-allograft tissue327 reports
- MOSAIC® 305C25Medtronic, Inc. · heart-valve, non-allograft tissue2 deaths324 reports
- FREESTYLE® FR995-27Medtronic, Inc. · heart-valve, non-allograft tissue2 deaths318 reports
- FREESTYLE® FR995-29Medtronic, Inc. · heart-valve, non-allograft tissue288 reports
- FREESTYLE® FR99525Medtronic, Inc. · heart-valve, non-allograft tissue2 deaths280 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 13, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 13, 2026
- Page last rebuilt: Oct 13, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page